EC Number   |
Inhibitors |
Structure |
|---|
    2.4.2.1 | (+/-)-cis-1,1-difluoro-2-(tetrahydro-3-piranozyl)ethylphosphonic acid |
with (hypoxanthine-9-yl)methyl aglycone, i.e. Yokomatsu compound |
   |
| 2.4.2.1 | (+/-)-cis-1,1-difluoro-2-(tetrahydro-3-piranyl)ethylphosphonic acid with (hypoxanthine-9-yl)methyl aglycone |
multisubstrate analogue inhibitor |
|
| 2.4.2.1 | (3R,4R)-1-((9-deazahypoxanthin-9-yl)methyl)-4-fluoro-4-hydroxymethyl pyrrolidin-3-ol |
- |
|
| 2.4.2.1 | (3S)-3-(2-amino-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)-3-(3-chlorophenyl)propanoic acid |
IC50: 0.000036 mM |
|
| 2.4.2.1 | (3S,4R)-4-(guanin-9-yl)-3-hydroxypyrrolidin-1-N-ylcarbonylphosphonic acid |
competitive. For enzyme from cancer cell lines, Ki values are around 10 to 24 nM |
|
| 2.4.2.1 | (3S,4S)-1-((9-deazahypoxanthin-9-yl)methyl)-4-fluoro-4-hydroxymethyl pyrrolidin-3-ol |
- |
|
| 2.4.2.1 | (S)-3-(guanin-9-yl)pyrrolidin-N-ylcarbonylphosphonic acid |
competitive. For enzyme from cancer cell lines, Ki values widely vary from 16 to 100 nM |
|
| 2.4.2.1 | 1',9-methyl-immucillin-H |
- |
|
| 2.4.2.1 | 1,5-O-bis(N-benzyloxycarbonylglycyl)-2,3-O-isopropylidene beta-D-riboside |
- |
|
| 2.4.2.1 | 1,6-Dihydropurine riboside |
- |
|
